1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer – The ABCs of ADCs (antibody drug conjugates)
    Editorial

    Martin, J.; Zacholski, E.; O'Cearbhaill, R.; Matulonis, U.; Chen, L.
    Gynecologic Oncology Reports (2023)

    Fulltext@MSK | Save
  • Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review
    Review

    Jolles, S.; Giralt, S.; Kerre, T.; Lazarus, H. M.; Mustafa, S. S.; Ria, R.; Vinh, D. C.
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save
  • A phase I/II open-label study of molibresib for the treatment of relapsed/refractory hematologic malignancies
    Journal Article

    Dawson, M. A.; Borthakur, G.; Huntly, B. J. P.; Karadimitris, A.; Alegre, A.; Chaidos, A.; Vogl, D. T.; Pollyea, D. A.; Davies, F. E.; Morgan, G. J.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Enhancing CD19 chimeric antigen receptor T cells through memory-enriched T cells
    Editorial

    El Marabti, E.; Abdel-Wahab, O.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Therapeutic advances in relapsed and refractory peripheral T-cell lymphoma
    Review

    Stuver, R.; Moskowitz, A. J.
    Cancers (2023)

    Fulltext@MSK | Save
  • Oncogenic IDH1 mutation imparts therapeutically targetable metabolic dysfunction in multiple tumor types
    Editorial

    Robinson, T. M.; Levine, R. L.
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
    Correspondence

    Goldman, A.; Raschi, E.; Chapman, J.; Santomasso, B. D.; Pasquini, M. C.; Perales, M. A.; Shouval, R.
    Blood (2023)

    Fulltext@MSK | Save
  • Acquired BAX mutations in AML
    Editorial

    Kim, W. J.; Abdel-Wahab, O.
    Blood (2023)

    Fulltext@MSK | Save
  • Investigating the relationship between cytotoxic T lymphocyte mechanical output and metabolism
    Meeting Abstract

    Wong, Y. Y.; de Jesus, M.; Huse, M.; Vardhana, S.
    Biophysical Journal (2023)

    Fulltext@MSK | Save
  • Bispecific antibodies for the treatment of B-cell lymphoma: Promises, unknowns, and opportunities
    Review

    Falchi, L.; Vardhana, S. A.; Salles, G. A.
    Blood (2023)

    Fulltext@MSK | Save